Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Express Scripts
Covington
Deloitte
Accenture
Novartis
Merck
Baxter
McKesson

Generated: October 18, 2017

DrugPatentWatch Database Preview

DURAMORPH PF Drug Profile

« Back to Dashboard

Which patents cover Duramorph Pf, and what generic Duramorph Pf alternatives are available?

Duramorph Pf is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in DURAMORPH PF is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: DURAMORPH PF

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list17
Clinical Trials: see list8
Patent Applications: see list8,614
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DURAMORPH PF at DailyMed

Pharmacology for Tradename: DURAMORPH PF

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
DURAMORPH PF
morphine sulfate
INJECTABLE;INJECTION018565-001Sep 18, 1984APRXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DURAMORPH PF
morphine sulfate
INJECTABLE;INJECTION018565-002Sep 18, 1984APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Novartis
Teva
Harvard Business School
Chinese Patent Office
Fuji
Accenture
Farmers Insurance
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot